GH Research PLC (GHRS)
NASDAQ: GHRS · IEX Real-Time Price · USD
11.05
-0.60 (-5.15%)
At close: Jul 19, 2024, 4:30 PM
11.07
+0.02 (0.18%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $574.91 million as of July 22, 2024. Its market cap has decreased by -12.21% in one year.
Market Cap
574.91M
Enterprise Value
417.95M
1-Year Change
-12.21%
Ranking
Category
Stock Price
$11.05
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $574.91M, a decrease of -28.88%. That is a compound annual growth rate of -10.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 574.90M | 90.55% |
| Dec 29, 2023 | 301.70M | -40.33% |
| Dec 30, 2022 | 505.60M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 586.90M |
| Varex Imaging | 580.78M |
| Orthofix Medical | 580.20M |
| Verve Therapeutics | 578.52M |
| Pharming Group | 577.28M |
| IRadimed | 572.42M |
| iTeos Therapeutics | 568.21M |
| Alector | 561.92M |